S&P 500

6.037,59

1,06%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
Reino Unido
LSE
Immunovia Ab (publ) (0G8X)
Immunovia Ab (publ) (0G8X) Notícias

0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:LSE:0G8X

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
19/12/2024	12:06	PR Newswire (US)	End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding	LSE:0G8X	Immunovia Ab (publ)
04/01/2024	12:59	PR Newswire (US)	Immunovia announces financial calendar for financial year 2024	LSE:0G8X	Immunovia Ab (publ)
21/11/2023	07:40	PR Newswire (US)	Bulletin from the extraordinary general meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
09/11/2023	05:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-September 2023	LSE:0G8X	Immunovia Ab (publ)
07/11/2023	12:14	PR Newswire (US)	Immunovia successfully completes discovery phase of next-generation test development	LSE:0G8X	Immunovia Ab (publ)
02/11/2023	07:02	PR Newswire (US)	Invitation to Immunovia's Q3 presentation	LSE:0G8X	Immunovia Ab (publ)
27/10/2023	04:06	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)	LSE:0G8X	Immunovia Ab (publ)
03/10/2023	06:01	PR Newswire (US)	Nomination Committee appointed for Immunovia AB (Publ)	LSE:0G8X	Immunovia Ab (publ)
30/08/2023	07:30	PR Newswire (US)	Immunovia Publishes Interim Report for January-June 2023	LSE:0G8X	Immunovia Ab (publ)
23/08/2023	15:08	PR Newswire (US)	Invitation to Immunovia's Q2 presentation	LSE:0G8X	Immunovia Ab (publ)
19/07/2023	13:47	PR Newswire (US)	Immunovia announces updated financial calendar	LSE:0G8X	Immunovia Ab (publ)
12/07/2023	04:15	PR Newswire (US)	Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection	LSE:0G8X	Immunovia Ab (publ)
09/06/2023	05:19	PR Newswire (US)	Chief Executive Officer, Jeff Borcherding, buys Immunovia shares	LSE:0G8X	Immunovia Ab (publ)
31/05/2023	07:16	PR Newswire (US)	Change in number of shares and votes in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
26/05/2023	08:43	PR Newswire (US)	Bulletin from the Annual General Meeting in Immunovia AB	LSE:0G8X	Immunovia Ab (publ)
23/05/2023	04:03	PR Newswire (US)	Immunovia Publishes Interim Report for January-March 2023	LSE:0G8X	Immunovia Ab (publ)
22/05/2023	13:55	PR Newswire (US)	Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)	LSE:0G8X	Immunovia Ab (publ)
17/05/2023	05:43	PR Newswire (US)	Invitation to Immunovia's Q1 presentation	LSE:0G8X	Immunovia Ab (publ)
06/05/2023	08:40	PR Newswire (US)	The board member Philipp von Hugo resigns from Immunovia's board at his own request	LSE:0G8X	Immunovia Ab (publ)
30/04/2023	07:17	PR Newswire (US)	Immunovia AB appoints new CEO	LSE:0G8X	Immunovia Ab (publ)
26/04/2023	09:44	PR Newswire (US)	Immunovia to discuss adoption of IMMray™ PanCan-d with key opinion leaders on May 3, 2023	LSE:0G8X	Immunovia Ab (publ)
25/04/2023	04:02	PR Newswire (US)	CONVENING NOTICE - ANNUAL GENERAL MEETING IN IMMUNOVIA AB (publ)	LSE:0G8X	Immunovia Ab (publ)
21/04/2023	12:25	PR Newswire (US)	Immunovia publishes the annual report for 2022	LSE:0G8X	Immunovia Ab (publ)
20/04/2023	03:54	PR Newswire (US)	Immunovia to participate in National Pancreas Foundation Webinar on Biomarkers and Liquid Biopsy for Early Detection of Pancreatic Cancer	LSE:0G8X	Immunovia Ab (publ)
12/04/2023	14:06	PR Newswire (US)	Immunovia announces outcome of the rights issue	LSE:0G8X	Immunovia Ab (publ)
17/03/2023	09:34	PR Newswire (US)	Immunovia publishes prospectus relating to the rights issue	LSE:0G8X	Immunovia Ab (publ)
01/03/2023	04:41	PR Newswire (US)	Immunovia appoints Karl Stone as new chief operating officer to develop R&D and operations	LSE:0G8X	Immunovia Ab (publ)
23/02/2023	04:54	PR Newswire (US)	Immunovia Publishes Full Year Report for 2022	LSE:0G8X	Immunovia Ab (publ)
20/02/2023	11:37	PR Newswire (US)	Invitation to Immunovia's Q4 presentation	LSE:0G8X	Immunovia Ab (publ)
20/02/2023	04:44	PR Newswire (US)	CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (publ)	LSE:0G8X	Immunovia Ab (publ)